browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
d74a9fb5-6423-4b15-840a-3bfe3668ebd7
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 20:31:14
Income (reported)
$40,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

HOOPER, LUNDY & BOOKMAN, P.C.

law firm

Contact
DEBRA JONES
Phone
+1 202-580-7702
Address
zip:20004, city:Washington, state:DC, street:401 9th Street NW Suite 550

Client

BRAINFUTURES

Nonprofit advocate for therapeutic treatments for mental health and substance use disorder

State
MD
Country
US
Effective date
2024-08-01

Issues lobbied + lobbyists

HCR — Health Issues

Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.

Lobbyists:
  • LISA LAYMAN — covered position: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MED — Medical/Disease Research/Clinical Labs

Issues related to a pathway for FDA approval of psychedelic drugs and therapies; issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; Public Law No: 119-26, related to implementation of research provisions.

Lobbyists:
  • LISA LAYMAN — covered position: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

H.R. 7148/Public Law No: 119-75, psychedelic therapies for treatment of mental health and substance use disorders related to the FY26 budget for the Department of Health and Human Services; FY2027 budget related to psychedelic therapies for treatment of mental health and substance use disorders.

Lobbyists:
  • LISA LAYMAN — covered position: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Government entities lobbied: HOUSE OF REPRESENTATIVES

VET — Veterans

H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025, S. 4220 - Veterans Health Administration Novel Therapeutics Preparedness Act.

Lobbyists:
  • LISA LAYMAN — covered position: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Government entities lobbied: HOUSE OF REPRESENTATIVES

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.